Transcriptional regulators of hepatic gluconeogenesis.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 189, doi. 10.1007/s12272-013-0018-5
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2013 AND VI 36 AND IP 2
Results: 11
1
2
Genetics of type 2 diabetes and potential clinical implications.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 167, doi. 10.1007/s12272-013-0021-x
- By:
- Publication type:
- Article
3
Role of autophagy in the progression from obesity to diabetes and in the control of energy balance.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 223, doi. 10.1007/s12272-013-0024-7
- By:
- Publication type:
- Article
4
Causal effects of synthetic chemicals on mitochondrial deficits and diabetes pandemic.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 178, doi. 10.1007/s12272-013-0022-9
- By:
- Publication type:
- Article
5
Latest research and development trends in non-insulin anti-diabetics.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 145, doi. 10.1007/s12272-013-0016-7
- By:
- Publication type:
- Article
6
Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 230, doi. 10.1007/s12272-013-0019-4
- By:
- Publication type:
- Article
7
Editorial note.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
8
Where are we now in diabetic research?
- Published in:
- 2013
- By:
- Publication type:
- Editorial
9
Implications of microRNAs in the pathogenesis of diabetes.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 154, doi. 10.1007/s12272-013-0017-6
- By:
- Publication type:
- Article
10
Molecular mechanisms of central leptin resistance in obesity.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 201, doi. 10.1007/s12272-013-0020-y
- By:
- Publication type:
- Article
11
Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 Diabetes.
- Published in:
- Archives of Pharmacal Research, 2013, v. 36, n. 2, p. 208, doi. 10.1007/s12272-013-0023-8
- By:
- Publication type:
- Article